CVS HEALTH Corp (CVS) operating KPIs
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$90.25−0.08 (-0.09%)
Close on Oct 30, 2026Market cap $115.43BP/E 23.9Yield 2.95%
Cvs Health labcorp Holdings (LH) — Total Revenues ($M)
Annual figures from Cvs Health's filings and investor materials
Latest, FY2025
13,952
Period ended Dec 31, 2025
Change on a year earlier
+7.2%
13,009 in FY2024
History
10 years
Since FY2016
Sources
1
Labcorp Holdings Inc. SEC 10-K (XBRL)
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Labcorp Holdings (LH) — Total Revenues ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 13,952 | +7.2% | Labcorp Holdings Inc. SEC 10-K (XBRL) ↗ |
| FY2024 | Dec 31, 2024 | 13,009 | +7.0% | Labcorp Holdings Inc. SEC 10-K (XBRL) ↗ |
| FY2023 | Dec 31, 2023 | 12,162 | +2.5% | Labcorp Holdings Inc. SEC 10-K (XBRL) ↗ |
| FY2022 | Dec 31, 2022 | 11,864 | -9.7% | Labcorp Holdings Inc. SEC 10-K (XBRL) ↗ |
| FY2021 | Dec 31, 2021 | 13,136 | -6.0% | Labcorp Holdings Inc. SEC 10-K (XBRL) ↗ |
| FY2020 | Dec 31, 2020 | 13,978 | +21.0% | Labcorp Holdings Inc. SEC 10-K (XBRL) ↗ |
| FY2019 | Dec 31, 2019 | 11,555 | +2.0% | Labcorp Holdings Inc. SEC 10-K (XBRL) ↗ |
| FY2018 | Dec 31, 2018 | 11,333 | +9.9% | Labcorp Holdings Inc. SEC 10-K (XBRL) ↗ |
| FY2017 | Dec 31, 2017 | 10,308 | +7.9% | Labcorp Holdings Inc. SEC 10-K (XBRL) ↗ |
| FY2016 | Dec 31, 2016 | 9,553 | – | Labcorp Holdings Inc. SEC 10-K (XBRL) ↗ |
Cite this data
StockData. (2026). Cvs Health Labcorp Holdings (LH) — Total Revenues ($M), annual FY2016–FY2025 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/peer_lh_revenue
See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.